Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05740137

Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy

Conditions: Colorectal Cancer, Colorectal Adenoma, Colorectal Neoplasms

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 800
Sponsor: Ismail Gögenur

Location: Denmark

Summary

The goal of this cluster randomized multicenter controlled clinical trial (RCT) is to investigate whether a combined real time computer-aided polyp detection (CADe) and computer-aided polyp characterization (CADx) system (GI Genius, Medtronic) can increase the adenoma detection rate (ADR) and reduce the performance variability among endoscopists.Participants will be randomized (1:1) to either receive an AI-assisted colonoscopy (AIC) or a conventional colonoscopy (CC).If there is a comparison group: Researchers will compare the AIC-group and the CC-group to see if AIC can increase the ADR significantly.

Eligibility Criteria

Inclusion Criteria:Referred for screening colonoscopy due to a positive faecal immunochemical test (FIT) or forDiagnostic colonoscopy due to symptoms/signs orPost-polypectomy surveillance colonoscopy (only patients who had all detected polyps removed in the previous colonoscopy)Exclusion Criteria:Referral for removal of previous detected polypsEmergency colonoscopyControl colonoscopy due to inflammatory bowel disease (IBD)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05740137). StuddyBuddy aggregates publicly available trial information.